These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 34263258)

  • 1. Hospitalized Older Patients with
    Shin JH; Hays RA; Warren CA
    Adv Geriatr Med Res; 2021; 3(2):. PubMed ID: 34263258
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fecal Microbiota Transplant Decreases Mortality in Patients with Refractory Severe or Fulminant Clostridioides difficile Infection.
    Cheng YW; Phelps E; Nemes S; Rogers N; Sagi S; Bohm M; El-Halabi M; Allegretti JR; Kassam Z; Xu H; Fischer M
    Clin Gastroenterol Hepatol; 2020 Sep; 18(10):2234-2243.e1. PubMed ID: 31923639
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of Fecal Microbiota Transplantation for Recurrent C. Difficile Infection in Inflammatory Bowel Disease.
    Tariq R; Disbrow MB; Dibaise JK; Orenstein R; Saha S; Solanky D; Loftus EV; Pardi DS; Khanna S
    Inflamm Bowel Dis; 2020 Aug; 26(9):1415-1420. PubMed ID: 31821444
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Successful use of early, repeat fecal microbiota transplantation for initial treatment of severe, refractory Clostridioides difficile colitis.
    Cappetto CM
    Am J Health Syst Pharm; 2021 Jul; 78(15):1374-1381. PubMed ID: 33851215
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fecal microbiota transplant for treatment of Clostridium difficile infection in immunocompromised patients.
    Kelly CR; Ihunnah C; Fischer M; Khoruts A; Surawicz C; Afzali A; Aroniadis O; Barto A; Borody T; Giovanelli A; Gordon S; Gluck M; Hohmann EL; Kao D; Kao JY; McQuillen DP; Mellow M; Rank KM; Rao K; Ray A; Schwartz MA; Singh N; Stollman N; Suskind DL; Vindigni SM; Youngster I; Brandt L
    Am J Gastroenterol; 2014 Jul; 109(7):1065-71. PubMed ID: 24890442
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Faecal microbiota transplantation for Clostridioides difficile infection].
    Waldbaum C; López F; Antelo P; Sorda J
    Medicina (B Aires); 2020; 80(6):633-639. PubMed ID: 33254107
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term durability and safety of fecal microbiota transplantation for recurrent or refractory Clostridioides difficile infection with or without antibiotic exposure.
    Lee CH; Chai J; Hammond K; Jeon SR; Patel Y; Goldeh C; Kim P
    Eur J Clin Microbiol Infect Dis; 2019 Sep; 38(9):1731-1735. PubMed ID: 31165961
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Systematic Review with Meta-Analysis: Fecal Microbiota Transplantation for Severe or Fulminant Clostridioides difficile.
    Tixier EN; Verheyen E; Luo Y; Grinspan LT; Du CH; Ungaro RC; Walsh S; Grinspan AM
    Dig Dis Sci; 2022 Mar; 67(3):978-988. PubMed ID: 33748913
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fecal Microbiota Transplantation for Fulminant Clostridioides Difficile Infection: A Combined Medical and Surgical Case Series.
    Spartz EJ; Estafanos M; Mallick R; Gaertner W; Vakayil V; Jahansouz C; Aggarwal R; Ikramuddin S; Khoruts A; Harmon JV
    Cureus; 2023 Feb; 15(2):e34998. PubMed ID: 36938160
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fecal Microbiota Transplantation for Severe or Fulminant
    Song YN; Yang DY; Veldhuyzen van Zanten S; Wong K; McArthur E; Song CZ; Ianiro G; Cammarota G; Kelly C; Fischer M; Russell L; Kao D
    J Can Assoc Gastroenterol; 2022 Feb; 5(1):e1-e11. PubMed ID: 35118227
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Real-world Effectiveness of Fecal Microbiota Transplantation for First or Second Clostridioides difficile Infection.
    Paaske SE; Baumwall SMD; Rubak T; Birn FH; Rågård N; Kelsen J; Hansen MM; Svenningsen L; Krarup AL; Fernis CMC; Neumann A; Lødrup AB; Glerup H; Vinter-Jensen L; Helms M; Erikstrup LT; Grosen AK; Mikkelsen S; Erikstrup C; Dahlerup JF; Hvas CL
    Clin Gastroenterol Hepatol; 2024 Jun; ():. PubMed ID: 38871148
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fecal Microbiota Transplantation Is Safe and Effective in Patients With Clostridioides difficile Infection and Cirrhosis.
    Cheng YW; Alhaffar D; Saha S; Khanna S; Bohm M; Phelps E; Ghabril M; Orman E; Sashidhar S; Rogers N; Xu H; Khoruts A; Vaughn B; Kao D; Wong K; Cammarota G; Ianiro G; Dhere T; Kraft CS; Mehta N; Woodworth MH; Allegretti JR; Nativ L; Marcus J; El-Nachef N; Fischer M
    Clin Gastroenterol Hepatol; 2021 Aug; 19(8):1627-1634. PubMed ID: 32645451
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term follow-up of colonoscopic fecal microbiota transplant for recurrent Clostridium difficile infection.
    Brandt LJ; Aroniadis OC; Mellow M; Kanatzar A; Kelly C; Park T; Stollman N; Rohlke F; Surawicz C
    Am J Gastroenterol; 2012 Jul; 107(7):1079-87. PubMed ID: 22450732
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fecal Microbiota Transplant in Severe and Non-Severe
    Popa D; Neamtu B; Mihalache M; Boicean A; Banciu A; Banciu DD; Moga DFC; Birlutiu V
    J Clin Med; 2021 Dec; 10(24):. PubMed ID: 34945118
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Factors Associated With Fecal Microbiota Transplant Failure in the Treatment of Recurrent Clostridioides difficile Infection: A Single-Center Retrospective Study.
    Warraich F; Sohail SH; Knee A; Smith J; Schlecht H; Skiest D
    Cureus; 2023 Sep; 15(9):e45118. PubMed ID: 37842346
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Factors Related to Outcomes of Fecal Microbiota Transplantation in Patients with
    Yoon H; Shim HI; Seol M; Shin CM; Park YS; Kim N; Lee DH
    Gut Liver; 2021 Jan; 15(1):61-69. PubMed ID: 32839363
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Faecal microbiota transplantation for treatment of recurrent or refractory
    Lui RN; Wong SH; Lau LHS; Chan TT; Cheung KCY; Li A; Chin ML; Tang W; Ching JYL; Lam KLY; Chan PKS; Wu JCY; Sung JJY; Chan FKL; Ng SC
    Hong Kong Med J; 2019 Jun; 25(3):178-182. PubMed ID: 31178437
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-Term Efficacy and Safety of Fecal Microbiota Transplantation for C. difficile Infections Across Academic and Private Clinical Settings.
    Dogra S; Oneto C; Sherman A; Varughese R; Yuen A; Sherman I; Cohen A; Luo Y; Chen LA
    J Clin Gastroenterol; 2023 Nov-Dec 01; 57(10):1024-1030. PubMed ID: 36227005
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The outcome and long-term follow-up of 94 patients with recurrent and refractory Clostridium difficile infection using single to multiple fecal microbiota transplantation via retention enema.
    Lee CH; Belanger JE; Kassam Z; Smieja M; Higgins D; Broukhanski G; Kim PT
    Eur J Clin Microbiol Infect Dis; 2014 Aug; 33(8):1425-8. PubMed ID: 24627239
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-Term Efficacy and Safety of Fecal Microbiota Transplantation for Treatment of Recurrent Clostridioides difficile Infection.
    Perler BK; Chen B; Phelps E; Allegretti JR; Fischer M; Ganapini V; Krajiceck E; Kumar V; Marcus J; Nativ L; Kelly CR
    J Clin Gastroenterol; 2020 Sep; 54(8):701-706. PubMed ID: 32011405
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.